Skip to content
Home/Companies/Biotech/Cleara Biotech
Cleara Biotech

Cleara Biotech

Biotech·Netherlands·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Cleara Biotech?

Cleara Biotech is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund II (2021 vintage), since 2022.

Hand-verified · updated 2026-07-03

Apollo Health Ventures
Investor
Apollo Health Ventures
Apollo Health Ventures Fund II · 2021 · Life Sciences VC

Key facts

HQNetherlands
SectorBiotech
StatusActive
Websitewww.clearabiotech.com

More from Apollo Health Ventures Fund II

Other portfolio companies in the same fund.

Therini Bio
Therini Bio
Active
BiotechUS· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Auron Therapeutics
Auron Therapeutics
Active
BiotechUS· 2022
Focal Biosciences
Focal Biosciences
Active
BiotechSwitzerland· 2022
Bloom Science
Bloom Science
Active
BiotechUS· 2021
HAYA Therapeutics
HAYA Therapeutics
Active
BiotechSwitzerland· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Cleara Biotech

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cleara Biotech?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cleara Biotech.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue